Brown & Brown, Inc. (BRO) has reported a robust 35.4% year-over-year increase in net revenue for Q3, yet the company’s shares fell more than 6% following the earnings announcement on October 27. Despite a market cap of approximately $26.77 billion and an industry-leading EBITDAC margin, investor sentiment remains low as shares have declined 38.2% from their 52-week high and 23.8% over the past year. Price target downgrades from top analysts, including a cut from BofA, raise further concerns about the company’s valuation in the face of its somewhat lower return on equity compared to industry averages.
“Brown & Brown, Inc. (BRO) · markets and sells · insurance products and services”
“Brown & Brown, Inc. (BRO) · valued at · $26.8 billion · market cap”
“Brown & Brown, Inc. (BRO) · provides · risk management, employee benefit administration, and managed health care services”
“Brown & Brown, Inc. (BRO) · fits description of · large-cap stocks”
“Brown & Brown, Inc. (BRO) · slipped · 38.2% · from its 52-week high”
“Brown & Brown, Inc. (BRO) · declined · 18.6% · over the past three months”
“Brown & Brown, Inc. (BRO) · reported · Q3 results”
“Brown & Brown, Inc. BRO · shares are trading at · a discount compared with the Zacks Brokerage Insurance industry · true”
“Brown & Brown, Inc. BRO · forward price-to-earnings multiple · 16.72X · lower than the industry average of 17.49X”
“Brown & Brown, Inc. BRO · market capitalization · $26.77 billion · true”
“Shares of Brown & Brown · have lost · 23.8% in the past year · compared with the industry’s decline of 27.4%”
“Brown & Brown · has an industry-leading adjusted EBITDAC margin · true · true”